Ultracentrifuge market projected to reach $2.36 billion by 2030

The ultracentrifuge market is expected to rise from $1.42 billion in 2025 to $1.58 billion in 2026 and then reach $2.36 billion by 2030, according to The Business Research Company. Growth is being driven by infectious disease diagnostics, personalized medicine, and expanding use in biopharma and research labs.

Why it matters: - Ultracentrifuges are core lab tools for separating proteins, nucleic acids, viruses, and other particles at very high speeds. - Rising demand in diagnostics, research, and biomanufacturing is expanding the market for equipment that supports molecular-level analysis. - The market outlook points to stronger demand for automation, high-throughput workflows, and precision medicine applications.

What happened: - The Business Research Company released a new ultracentrifuge market study on September 1, 2026. - The report estimates the market will grow from $1.42 billion in 2025 to $1.58 billion in 2026. - The report projects the market will reach $2.36 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be one of the fastest-growing regions.

The details: - Ultracentrifuges separate particles by size, shape, and density by spinning at speeds often above 100,000 RPM. - The equipment is used to isolate and purify proteins, nucleic acids, and viruses. - The report links recent growth to advances in molecular biology, protein and nucleic acid research, biotechnology labs, virus isolation methods, and academic research institutions. - Future growth is expected to be supported by precision medicine, automation in lab systems, high-throughput centrifugation, biopharmaceutical manufacturing, and use in polymer and material sciences. - The report highlights future trends including high-speed molecular separations, automated sample handling, multifunctional centrifuge platforms, AI-driven protocol optimization, and remote operation. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. - The Business Research Company said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, key technologies, future trends, and updated graphics and tables. - A free sample of the report is available. - The full market report is also available.

Between the lines: - The infectious disease driver underscores how the market depends not just on research spending, but also on public health needs and laboratory response capacity. - Personalized medicine is becoming a stronger demand driver as more therapies rely on precise biomolecule analysis. - The regional split suggests North America remains the center of current demand, while Asia-Pacific is gaining momentum as research and healthcare infrastructure expands.

What's next: - The market is expected to keep growing as lab automation and precision medicine adoption increase. - Reported product and workflow trends suggest ultracentrifuge makers will compete more on speed, software, and remote operation capabilities. - Expansion in biopharmaceutical manufacturing and materials science should add new use cases through 2030. - The Business Research Company is promoting expert access through Saumya Sahay and company contact channels for readers seeking more detail.